Business The science behind a fond farewell Published 3 years ago on 24 September 2021 By Terry Power Share Tweet What motivation science has to say about goodbyes. Plus, GE’s $1.45 billion acquisition and monoclonal antibody bottleneck. Read More Related Topics:biogen aduhelmcoronavirusCOVIDcovid treatment costsdigital healthfarewellfondfortune the capsuleGE Healthcaremonoclonal antibodiessciencethe capsulethe science of a farewell Up Next Will Robinhood force crypto trading to go ‘no-fee’? Don't Miss Regulators have Big Tech in a corner Continue Reading You may like Decoding the data of the Chinese mpox outbreak China is suddenly dealing with another public health crisis: mpox Covid hasn’t entirely gone away—here’s where we stand The Download: how AI is changing science, and limits on White House contact with tech firms Eric Schmidt: This is how AI will transform how science gets done Did US Help Fund Coronavirus Research In Controversial Wuhan Lab? Business These fast-growing Sun Belt cities suffer from high inflation Published 3 years ago on 4 May 2022 By Terry Power U.S. migration hotspots tend to have the highest inflation | Fortune You need to enable JavaScript to view this site. Continue Reading Business The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to Published 3 years ago on 4 May 2022 By Terry Power Oligarch sanctions: U.S. seizing $325 million megayacht in Fiji. The question is which Russian billionaire it belongs to | Fortune You need to enable JavaScript to view this site. Continue Reading Business Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several Published 3 years ago on 4 May 2022 By Terry Power Fed rate hike: decision day rattles markets as investors worry that a giant ‘once-in-a-generation’ hike will be one of several this year | Fortune You need to enable JavaScript to view this site. Continue Reading